Tips to mitigate the risk that medtech teams keep leaving unowned as artificial intelligence moves into Class II and III medical devices. By Dr. Sarah Matt, Vital Werks By the time a clinician trusts a wrong output from your artificial-intelligence-powered device, every decision that made the trust possible was made years earlier. How many decisions…
The post AI is moving inside the device. Who owns the clinical risk? appeared first on Medical Design and Outsourcing.